These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25804087)

  • 21. Intralesional interferon-alpha-2B injections for the treatment of Peyronie's disease.
    Dang G; Matern R; Bivalacqua TJ; Sikka S; Hellstrom WJ
    South Med J; 2004 Jan; 97(1):42-6. PubMed ID: 14746421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.
    Favilla V; Russo GI; Zucchi A; Siracusa G; Privitera S; Cimino S; Madonia M; Cai T; Cavallini G; Liguori G; D'Achille G; Silvani M; Franco G; Verze P; Palmieri A; Torrisi B; Mirone V; Morgia G
    Andrology; 2017 Jul; 5(4):771-775. PubMed ID: 28718527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local interferon-alpha 2b is not an effective treatment in early-stage Peyronie's disease.
    Wegner HE; Andresen R; Knispel HH; Miller K
    Eur Urol; 1997; 32(2):190-3. PubMed ID: 9286652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study.
    Levine LA; Newell M; Taylor FL
    J Sex Med; 2008 Jun; 5(6):1468-73. PubMed ID: 18373527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of penile extender device in the treatment of penile curvature as a result of Peyronie's disease. Results of a phase II prospective study.
    Gontero P; Di Marco M; Giubilei G; Bartoletti R; Pappagallo G; Tizzani A; Mondaini N
    J Sex Med; 2009 Feb; 6(2):558-66. PubMed ID: 19138361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis.
    Hellstrom WJG; Tue Nguyen HM; Alzweri L; Chung A; Virasoro R; Tapscott A; Ziegelmann M; Trost L; Gelbard M
    J Urol; 2019 Apr; 201(4):777-782. PubMed ID: 30672843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peyronie's disease: pharmacological treatments and limitations.
    Li EV; Esterquest R; Pham MN; Panken EJ; Amarasekera C; Siebert A; Bajic P; Levine LA
    Expert Rev Clin Pharmacol; 2021 Jun; 14(6):703-713. PubMed ID: 33719851
    [No Abstract]   [Full Text] [Related]  

  • 28. The Effect of Adjunct Mechanical Traction on Penile Length in Men Undergoing Primary Treatment for Peyronie's Disease: A Systematic Review and Meta-analysis.
    Haney NM; Kohn TP; Nichols PE; Jg Hellstrom W
    Urology; 2018 Dec; 122():110-115. PubMed ID: 30099127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of Management Options for Active-Phase Peyronie's Disease.
    Brimley SC; Yafi FA; Greenberg J; Hellstrom WJG; Tue Nguyen HM; Hatzichristodoulou G
    Sex Med Rev; 2019 Apr; 7(2):329-337. PubMed ID: 30503796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intralesional verapamil prevents the progression of Peyronie's disease.
    Bennett NE; Guhring P; Mulhall JP
    Urology; 2007 Jun; 69(6):1181-4. PubMed ID: 17572211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
    Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
    BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.
    Ziegelmann MJ; Viers BR; McAlvany KL; Bailey GC; Savage JB; Trost LW
    J Urol; 2016 Apr; 195(4 Pt 1):1051-6. PubMed ID: 26476353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical management of Peyronie's disease.
    Hellstrom WJ
    J Androl; 2009; 30(4):397-405. PubMed ID: 18974422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasound and soft-tissue radiography to monitor local interferon-alpha 2B treatment in Peyronie's disease.
    Andresen R; Wegner HE; Banzer D; Miller K
    Acta Radiol; 1996 May; 37(3 Pt 1):352-6. PubMed ID: 8845268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penile Stretching as a Treatment for Peyronie's Disease: A Review.
    Cowper MG; Burkett CB; Le TV; Scherzer N; Hellstrom WJG
    Sex Med Rev; 2019 Jul; 7(3):508-515. PubMed ID: 30612978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining predictors of response to intralesional verapamil injection therapy for Peyronie's disease.
    Moskovic DJ; Alex B; Choi JM; Nelson CJ; Mulhall JP
    BJU Int; 2011 Nov; 108(9):1485-9. PubMed ID: 21733073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Penile Traction Therapy and Vacuum Erection Devices in Peyronie's Disease.
    Avant RA; Ziegelmann M; Nehra A; Alom M; Kohler T; Trost L
    Sex Med Rev; 2019 Apr; 7(2):338-348. PubMed ID: 29631979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application of traction therapy for Peyronie's disease: present and prospect].
    He ZH; Lu YP
    Zhonghua Nan Ke Xue; 2014 Jan; 20(1):78-82. PubMed ID: 24527543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary Review of Peyronie's Disease Treatment.
    Capoccia E; Levine LA
    Curr Urol Rep; 2018 May; 19(7):51. PubMed ID: 29774446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FastSize Medical Extender for the treatment of Peyronie's disease.
    Levine LA; Newell MM
    Expert Rev Med Devices; 2008 May; 5(3):305-10. PubMed ID: 18452379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.